INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Company

SOLENO THERAPEUTICS INC

Filed

May 18, 2023

Period of Report

May 11, 2023

Accession Number

0001062993-23-011620